Shuhei Nakanishi

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial

Daisuke Yabe, Jiro Nakamura, Hideaki Kaneto et al. · The Lancet Diabetes & Endocrinology · 2020 · 182 citations

Diabetes Management, Cardiovascular Disease, Medicine +8

Decreased Total and High Molecular Weight Adiponectin Are Independent Risk Factors for the Development of Type 2 Diabetes in Japanese-Americans

Reiko Nakashima, Nozomu Kamei, Kiminori Yamane et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 158 citations · Full text

Effectiveness of Semmes–Weinstein monofilament examination for diabetic peripheral neuropathy screening

Nozomu Kamei, Kiminori Yamane, Shuhei Nakanishi et al. · Journal of Diabetes and its Complications · 2005 · 150 citations

Semmes–weinstein Monofilament Examination, Diabetes, Diabetic Neuropathy +4

Elevated C-Reactive Protein Is a Risk Factor for the Development of Type 2 Diabetes in Japanese Americans

Shuhei Nakanishi, Kiminori Yamane, Nozomu Kamei et al. · Diabetes Care · 2003 · 146 citations · Full text

A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane

Shuhei Nakanishi, Kiminori Yamane, Nozomu Kamei et al. · Metabolism · 2005 · 114 citations

Obesity, Metabolic Syndrome, Medicine +10